Newsroom
Search results
Showing matches with:
A drug alleviates trauma-induced psychological effects in female mice
09 04 2025
According to a study led by Dr. Raül Andero, the drug Osanetant could reduce the intensity at which the fear memory is consolidated, thus preventing the onset of post-traumatic stress disorder (PTSD). The research, conducted with female mice, highlights important sex differences in fear processing.
Gene therapy reverses symptoms of rare neurological disease in animal models
31 03 2025
A recent study led by Dr Assumpció Bosch demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC), even when treatment begins after symptom onset.
Dr. Waldo Nogueira Takes Part in the 'España ATRAE' Meeting
19 03 2025
The event brought together 40 renowned researchers to advance science in Spain and foster collaborations.
DIPOLE Project Kick-Off: Advancing Personalized Epilepsy Treatment
13 03 2025
On February 20th, 2025 took place the official launch of the DIPOLE project, a collaborative initiative aimed at advancing personalized treatment for pharmacoresistant epilepsies.
Patent on Fezolinetant Use
07 03 2025
Professor Raul Andero’s laboratory, Translational Mechanisms of Fear Memory, has registered a European patent on the use of Fezolinetant—a drug originally developed to treat vasomotor symptoms associated with menopause—for modulating the consolidation of aversive memories.
Seventeen female researchers from the Institute in the "Ranking of Spanish Women Researchers" (CSIC)
19 02 2025
Seventeen female researchers from the Institute have been recognized in the recent "Ranking of Spanish Women Researchers" published this February.
Lab-designed chimeric protein shows beneficial effects in animal models of Alzheimer's disease
10 02 2025
A research team at the Institute has developed a new protein capable of improving memory and reducing Tau protein levels in animal models of Alzheimer's disease. The new compound, HEBE, generated by fusing three proteins, represents a new approach in the search for new strategies to tackle the disease.
Latest Advances in Understanding How Traumatic Memories Are Processed
07 02 2025
A review published in Molecular Psychiatry by ICREA Professor Dr. Raül Andero delves into the intricate mechanisms underlying fear memory, offering a comprehensive analysis that integrates findings from both human and animal studies. Read the publication
The two proteins involved in Alzheimer's disease affect brain circuits differently
06 02 2025
A research team from the Institute has discovered that the two key pathological hallmarks of Alzheimer’s—tau protein and beta-amyloid—affect brain circuits in distinct yet synergistic ways, particularly those linked to memory and emotions. Read the article
Workshop on Miniscopes at Institut de Neurociències
05 02 2025
The AnderoLab is hosting an advanced workshop on in vivo calcium imaging using Miniscopes from June 10th to 12th, 2025. This intensive three-day course will equip participants with essential skills for studying neuronal activity in freely moving rodents.